Share on StockTwits

Uniqure BV (NASDAQ:QURE) announced its earnings results on Tuesday. The company reported ($1.35) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.55) by $0.80, Analyst RN reports.

Uniqure BV (NASDAQ:QURE) opened at 11.18 on Wednesday. Uniqure BV has a 52 week low of $8.29 and a 52 week high of $18.75. The stock has a 50-day moving average of $10.95 and a 200-day moving average of $12.20. The company’s market cap is $196.7 million.

Uniqure BV is a pharmaceutical company based in the Netherlands. It is primarily engaged in the field of gene therapy for orphan diseases.

Receive News & Ratings for Uniqure BV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniqure BV and related companies with Analyst Ratings Network's FREE daily email newsletter.